Infect Chemother.
2021 Dec;53(4):796-796. 10.3947/ic.2021.0110.
Ruxolitinib and Severe COVID-19
- Affiliations
-
- 1Private Academic Consultant, Bangkok, Thailand
- 2Department of Community Medicine, Dr DY Patil University, Pune, India
- KMID: 2524076
- DOI: http://doi.org/10.3947/ic.2021.0110
Abstract
- no abstract available.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Ruxolitinib and the Mitigation of Severe COVID-19: A Systematic Review and Meta-analysis
- COVID-19 and Cancer: Questions to Be Answered
- How to Cope with COVID-19 in Patients with Inflammatory Bowel Disease
- The Role of COVID-19 Vaccination for Patients With Atherosclerotic Cardiovascular Disease in the Upcoming Endemic Era
- COVID-19 and Sleep
